Search results
Results From The WOW.Com Content Network
The name "cannabinoid hyperemesis syndrome" was also coined at this time. The report focused on nine patients who were chronic cannabis users who presented with cyclical vomiting illness. One woman in the study reported that warm baths provided the only relief from the nausea, severe vomiting, and stomach pain, and reportedly burned herself in ...
Long term cannabis users are at risk for developing cannabinoid hyperemesis syndrome (CHS), characterized by recurrent bouts of intense vomiting. The mechanism behind CHS is poorly understood and is contrary to the antiemetic properties of cannabis and cannabinoids. [73]
Aprepitant has been identified as having strong potential in treating protracted vomiting episodes in individuals with cannabinoid hyperemesis syndrome. [25] This syndrome is characterized by nausea , cyclical vomiting , and cramping abdominal pain resulting from prolonged, frequent cannabis use.
[27] [28] Long-term cannabis use may cause nausea and vomiting, a condition known as cannabinoid hyperemesis syndrome (CHS). [ 29 ] A 2016 Cochrane review said that cannabinoids were "probably effective" in treating chemotherapy-induced nausea in children, but with a high side-effect profile (mainly drowsiness, dizziness, altered moods, and ...
Long-term cannabis users are at risk for developing cannabinoid hyperemesis syndrome (CHS), characterized by recurrent bouts of intense vomiting and abdominal cramping during or within 48 hours of heavy cannabis use. [112] The mechanism behind CHS is poorly understood and is contrary to the antiemetic properties of cannabis and cannabinoids.
Clinical trials (i) Clinical trials looking at cannabis in pediatric neurological disease. (ii) Neuro-degenerative and neuro-metabolic disorders of childhood [12] Type 1 cannabinoid receptor (CB1R) Pharmacology of the endocannabinoid system and the type 1 cannabinoid receptor (CB1R). [13] Microbiome studies Project under development by the ...
For premium support please call: 800-290-4726 more ways to reach us
Reye's syndrome, for example, is a potentially fatal complication of aspirin therapy in children that is very rare in adults. The 2002 Best Pharmaceuticals for Children Act, allowed the FDA to request National Institutes of Health -sponsored testing for pediatric drug testing, although these requests are subject to NIH funding constraints.